Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to $6.9 million.

  • Adma Biologics' Prepaid Assets fell 2739.65% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 2739.65%. This contributed to the annual value of $8.0 million for FY2024, which is 5052.49% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Prepaid Assets is $6.9 million, which was down 2739.65% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Prepaid Assets registered a high of $9.5 million during Q3 2024, and its lowest value of $3.7 million during Q1 2024.
  • Over the past 5 years, Adma Biologics' median Prepaid Assets value was $5.5 million (recorded in 2022), while the average stood at $6.0 million.
  • Data for Adma Biologics' Prepaid Assets shows a peak YoY increase of 12959.1% (in 2025) and a maximum YoY decrease of 2739.65% (in 2025) over the last 5 years.
  • Over the past 5 years, Adma Biologics' Prepaid Assets (Quarter) stood at $4.3 million in 2021, then rose by 17.42% to $5.1 million in 2022, then grew by 4.69% to $5.3 million in 2023, then soared by 50.52% to $8.0 million in 2024, then decreased by 13.69% to $6.9 million in 2025.
  • Its last three reported values are $6.9 million in Q3 2025, $8.1 million for Q2 2025, and $8.6 million during Q1 2025.